Share Repurchase Plan and Issuances	9 Months Ended
Jan. 27, 2024
Share Repurchase Plan and Issuances
Share Repurchase Plan and Issuances	15. Share Repurchase Plan and Issuances The Company’s share repurchase program announced September 2015 was terminated by the Company’s Board of Directors in September 2022. There were no repurchases of the Company’s common stock during the nine months ended January 28, 2023. On September 8, 2022, the Company filed an S-3 shelf registration statement to offer and sell shares of the Company’s common stock, including a prospectus supplement in relation to an Open Market Sale Agreement^SM, also dated September 8, 2022, with Jefferies LLC relating to the proposed offer and sale of shares of our common stock having an aggregate offering price of up to $200,000,000 from time to time through Jefferies LLC as the sales agent. During the six months ended October 28, 2023, the Company completed the Open Market Sale Agreement^SM. During the six months ended October 28, 2023 the Company sold 807,370 shares, for total gross proceeds of $91,313,000, total proceeds received of $88,574,000, net of commission expense, and $88,437,000 net of equity issuance costs. During the three and nine months ended January 28, 2023, the Company sold 96,530 and 221,971 of its shares, respectively, for total gross proceeds of $8,710,000 and $21,439,000, respectively, total proceeds received of $8,449,000 and $20,796,000, net of commission expense, respectively, and $8,325,000 and $20,104,000 net of equity issuance costs, respectively. As of January 27, 2024, the Company has completed the Open Market Sale Agreement^SM and sold 1,917,100 of its shares for total gross proceeds of $200,000,000, total proceeds received of $193,999,000, net of commission expense and $193,086,000 net of equity issuance costs.

Share Repurchase Plan and Issuances

9 Months Ended

Jan. 27, 2024

15. Share Repurchase Plan and Issuances

The Company’s share repurchase program announced September 2015 was terminated by the Company’s Board of Directors in September 2022. There were no repurchases of the Company’s common stock during the nine months ended January 28, 2023.

On September 8, 2022, the Company filed an S-3 shelf registration statement to offer and sell shares of the Company’s common stock, including a prospectus supplement in relation to an Open Market Sale Agreement^SM, also dated September 8, 2022, with Jefferies LLC relating to the proposed offer and sale of shares of our common stock having an aggregate offering price of up to $200,000,000 from time to time through Jefferies LLC as the sales agent. During the six months ended October 28, 2023, the Company completed the Open Market Sale Agreement^SM. During the six months ended October 28, 2023 the Company sold 807,370 shares, for total gross proceeds of $91,313,000, total proceeds received of $88,574,000, net of commission expense, and $88,437,000 net of equity issuance costs. During the three and nine months ended January 28, 2023, the Company sold 96,530 and 221,971 of its shares, respectively, for total gross proceeds of $8,710,000 and $21,439,000, respectively, total proceeds received of $8,449,000 and $20,796,000, net of commission expense, respectively, and $8,325,000 and $20,104,000 net of equity issuance costs, respectively. As of January 27, 2024, the Company has completed the Open Market Sale Agreement^SM and sold 1,917,100 of its shares for total gross proceeds of $200,000,000, total proceeds received of $193,999,000, net of commission expense and $193,086,000 net of equity issuance costs.